切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Dihydroorotate dehydrogenase - p38 - Ca2 /calmodulin-dependent protein kinases (CaMKs)

19件产品中的 1-10

页面
每页
清除全部
  1. Pexmetinib (ARRY-614)
    B6012 Pexmetinib (ARRY-614)
    Target: p38|Tie-2
    Summary: p38 MAPK 和 Tie2/Tek 受体酪氨酸激酶的双重抑制剂
      ≥107.6 mg/mL
      insoluble in H2O
  2. KN-93 Phosphate
    B4969 KN-93 Phosphate
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)
    Summary: CaM激酶II抑制剂
      ≥29.95 mg/mL
      ≥20.7 mg/mL
  3. AL 8697
    B7784 AL 8697
    Target: p38
    Summary: 有效的p38α选择性抑制剂
      <40.24 mg/mL
      <20.12 mg/mL
  4. Rottlerin
    B6803 Rottlerin
     1 Citation
    中文名: 揪毒素
    Target: PKC|Ca2 /calmodulin-dependent protein kinases (CaMKs)|PRAK|MAPKAP-K2
    Summary: PKC抑制剂
      ≥23.6 mg/mL
      insoluble in H2O
  5. Anisomycin
    B6674 Anisomycin
    中文名: 茴香霉素
    Target: p38|JNK|SAPK
    Summary: JNK激动剂
      ≥26.5 mg/mL
      insoluble in H2O
  6. Autocamtide-2-related inhibitory peptide
    B6831 Autocamtide-2-related inhibitory peptide
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)
    Summary: 钙调蛋白依赖性蛋白激酶II(CaM激酶II,CaMKII)抑制剂
      ≥40.2 mg/mL
      ≥45.7 mg/mL
  7. KN-93 hydrochloride
    B1306 KN-93 hydrochloride
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)
    Summary: CaMK II抑制剂
      ≥26.9 mg/mL
      ≥5.51 mg/mL
  8. Teriflunomide
    B1850 Teriflunomide
    中文名: 特立氟胺
    Target: Dihydroorotate dehydrogenase
    Summary: 二氢乳清酸脱氢酶的抑制剂
      ≥13.5 mg/mL
      insoluble in H2O
  9. 1-NM-PP1
    B1299 1-NM-PP1
    Target: Cyclin-Dependent Kinases|Bcr-Abl|Src|Ca2 /calmodulin-dependent protein kinases (CaMKs)|c-Fyn
    Summary: Pp60c-src抑制剂
      ≥16.55 mg/mL
      insoluble in H2O
  10. SB 203580 hydrochloride
    B1285 SB 203580 hydrochloride
    Target: p38
    Summary: p38-MAPK特异性抑制剂
      ≥20.7 mg/mL
      insoluble in H2O

19件产品中的 1-10

页面
每页